PHAT vs AMGN: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Amgen Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
$13.19
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | PHAT | AMGN | Winner |
|---|---|---|---|
| Market Cap | $1.00B | $188.34B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.22 | AMGN |
| Revenue Growth | 0.9% | 0.1% | PHAT |
| Gross Margin | 87.1% | 70.8% | PHAT |
Analyze PHAT
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or AMGN a better investment?
Comparing PHAT and AMGN: Phathom Pharmaceuticals Inc has a market cap of $1.00B while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and AMGN?
PHAT (Phathom Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or AMGN?
PHAT has higher revenue growth at 0.9% vs 0.1% for AMGN.
Which company is more profitable: PHAT or AMGN?
Phathom Pharmaceuticals Inc (PHAT) has higher gross margins at 87.1% compared to 70.8% for AMGN.
Which is the larger company: PHAT or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $1.00B for PHAT.
Should I buy PHAT or AMGN in 2026?
Both PHAT and AMGN have investment merit. PHAT trades at $13.19 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and AMGN stock?
Key differences: Market Cap ($1.00B vs $188.34B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.9% vs 0.1%), Gross Margin (87.1% vs 70.8%).